Brownstone Research

None recorded.

• Trump Coin Promo Readable

  Front-endOld (Inactive)6.6/10
  2026-06-22· The Near Future Report· Teases: This promo contains multiple stock/coin teases. The primary crypto tease (the #1 "Trump coin") and three secondary stock teases are analyzed below. **Tease #1 — The #1 AI "Trump Coin"** Clues given: - AI-powered cryptocurrency (not a meme coin or pure blockchain play) - Building infrastructure for AI agents to operate on blockchain - "Proven project" with over $16 trillion in total transaction value - One of Trump's main crypto advisors made a "big investment" in it - SEC under Trump expected to approve an ETF for it (like Bitcoin and Ethereum ETFs) - Described as being at the center of the AI agents trend - Implied to be a mid-to-large cap coin (not a micro-cap like the comparison coins) Best prediction: **Fetch.ai (FET) / Artificial Superintelligence Alliance (ASI)** — now merged into the ASI Alliance token. This is the leading AI agent infrastructure coin on blockchain, has substantial transaction volume, is well-known in the crypto policy community, and has been discussed in ETF contexts. Alternative: **Render Network (RNDR)** or **Bittensor (TAO)**, both of which fit the AI infrastructure + blockchain profile. Confidence: Medium — the $16 trillion transaction value clue is the strongest differentiator but is difficult to verify without the coin name. --- **Tease #2 — Elon Musk's Silent Partner (Bonus Report #2)** Clues given: - Little-known company supplying Elon with "a key piece of technology" for his new $9 trillion AI product - The AI product has been in development for a decade - Elon planned to launch it "sometime in 2025" - Jeff claims to have personally tested the technology - Could put $30,000/year in the reader's pocket (suggesting a royalty, licensing, or recurring revenue model) - The product is described as Elon's "new AI product" — distinct from Tesla, SpaceX, Neuralink, and X Best prediction: This appears to reference **xAI's Grok** or a related product, with the supplier likely being a company in the AI inference chip or data center space. Given the $30K/year income angle, this may be a company with a dividend or buyback program. Possible candidates: **Cerebras Systems** (if public by then), **SambaNova**, or a publicly traded AI infrastructure supplier. The "decade in development" clue and personal testing claim suggest this could be referencing Tesla's **Optimus** robot or **Full Self-Driving** technology, making the supplier potentially a sensor or compute company like **Mobileye (MBLY)** or **Luminar Technologies (LAZR)**. Confidence: Low — too many Musk ventures fit the description; the unnamed product is the critical missing variable. --- **Tease #3 — "The Next Nvidia" (Bonus Report #3)** Clues given: - AI chip company with 50x the computing power of Nvidia's H100 - Tested at Los Alamos National Laboratory; performed 179x faster than world's most powerful supercomputer - Ken Griffin (Citadel) dumped $1.1B in Nvidia and bought this stock - Ken Fisher invested ~$5 billion - Steven Cohen, Cathie Wood, Paul Tudor Jones, George Soros also invested - "Most people have never heard of" it — implies it's not AMD or Intel - Controls no meaningful current market share (Nvidia has 80%) Best prediction: **AMD (AMD)** is the most obvious candidate given institutional ownership, but the "most people have never heard of" clue rules it out. The Los Alamos testing and 179x supercomputer performance strongly suggests **Cerebras Systems** (if recently IPO'd) or more likely **Groq** or **d-Matrix**. Among publicly traded options, **Cerebras** went public in late 2024. However, the billionaire investor list (Griffin, Fisher, Cohen, Wood, Jones, Soros) points to a publicly traded company with 13F filings. The most likely match given all clues is **Super Micro Computer (SMCI)** or **Marvell Technology (MRVL)** — but the chip performance claims most closely match **Cerebras** or a company like **Untether AI**. Among confirmed public companies with this investor profile: **Arm Holdings (ARM)** fits the institutional ownership but not the "unknown" framing. Confidence: Low — the performance claims (50x H100, 179x supercomputer) are extraordinary and don't match any publicly known chip at the time of writing, suggesting possible exaggeration or a very early-stage private company being described. --- **Tease #4 — Robotics Supplier (Bonus Report #4)** Clues given: - Little-known company supplying Tesla with "a key piece of sensor technology" - Likely to supply Optimus robot with sensors - Morgan Stanley recommended it as a key robotics play - 45 hedge funds investing in it Best prediction: **Cognex Corporation (CGNX)** (machine vision sensors, Morgan Stanley coverage, institutional ownership) or **Zebra Technologies (ZBRA)**. More likely: **Luminar Technologies (LAZR)** (lidar sensors for Tesla, institutional backing) or **Innoviz Technologies (INVZ)**. The Morgan Stanley recommendation and 45-hedge-fund ownership narrows it to a mid-cap with analyst coverage. **Cognex** or **Keyence** (private) are strong candidates; among pure-play robotics sensor suppliers to Tesla, **Mobileye** or **Luminar** remain top guesses. Confidence: Medium — the Tesla sensor supplier + Morgan Stanley + 45 hedge funds combination is specific enough to narrow the field significantly.

  1. Hook Strength: 8/10 — The White House opening, the "Trump coin" brand, and the immediate historical parallel to 2017 gains create a strong, politically resonant hook that will stop a Trump-aligned crypto-curious reader cold; the visual of Jeff standing in front of the White House is a credibility

• BNF Space

  Front-endActive7.0/10
  2026-06-16· The Near Future Report· Teases: **Primary Tease — SpaceX Pre-IPO Stake:** The promo's main offer is a mechanism to buy a "stake" in SpaceX before its IPO for as little as $500 "from your computer." SpaceX (SPACE — not yet publicly traded) is named explicitly. The investment vehicle is not named in the promo but is likely one of the following: - **SpaceX shares via a secondary market platform** (e.g., Forge Global, EquityZen, Hiive) — retail investors can buy existing SpaceX shares from employees/early investors on these platforms - **A SpaceX-linked ETF or fund** (e.g., ARK Space Exploration ETF — ARKX, or a similar vehicle) - **A pre-IPO investment platform** that aggregates retail capital into SpaceX Most likely prediction: **Secondary market platform purchase of SpaceX shares** (via Forge, EquityZen, or similar), given the "$500 minimum" and "as easy as buying any other stock" language. Confidence: **Medium** — the mechanism is deliberately withheld and the report is the unlock. --- **Secondary Tease — Robotics Supplier (Bonus Report #2):** Clues given: - "Little-known Elon Musk supplier" - Already supplying Tesla with "a key piece of sensor technology" - Expected to supply Optimus humanoid robot with sensors - Morgan Stanley recommended it as a key robotics play - 39 hedge funds currently invested - Described as "little-known" and smaller than Tesla Best prediction: **Luminar Technologies (LAZR)** — a lidar/sensor company with Tesla supply relationships, institutional backing, and robotics/autonomous vehicle exposure. Alternative: **Mobileye (MBLY)** — vision sensor technology, though larger and more widely known. Second alternative: **Cognex (CGNX)** — machine vision sensors used in factory automation. Confidence: **Low-Medium** — "sensor technology" for both Tesla and Optimus narrows the field but multiple candidates fit. --- **Tertiary Tease — "Next Nvidia" AI Chip (Bonus Report #3):** Clues given: - AI chip 21x more powerful than Nvidia's Blackwell GPU - Costs one-third less than Nvidia's chips - Consumes one-third less electricity - Tested at Los Alamos National Laboratories - Performed 179x faster than "the world's most powerful supercomputer" on a specific benchmark Best prediction: **Cerebras Systems** — known for wafer-scale AI chips with dramatically different architecture than Nvidia GPUs, has been benchmarked at national laboratories, and is positioned as a direct Nvidia alternative. Alternative: **Groq** (private) or **SambaNova Systems** (private) — both have national lab relationships but are not publicly traded. If the company must be publicly investable: **AMD** is too well-known; **Tenstorrent** is private. The Los Alamos connection and "179x faster than the most powerful supercomputer" benchmark language most closely matches **Cerebras** public claims. Confidence: **Medium** — the Los Alamos / supercomputer benchmark detail is distinctive and narrows the field significantly toward Cerebras, though it recently went public via IPO.

  1. Hook Strength: 8/10 — The "compress decades of wealth into a 24-hour window" opener is emotionally arresting, and the immediate reframe of SpaceX as an AI story rather than a rocket story creates genuine intellectual curiosity that pulls the reader forward. 2. Believability: 7/10 — Jeff Brown's c

• 2026-07-02EDITORIALThe Bleeding Edge
  A Golden Age of Supersonic Travel
  Jeff Brown analyzes the history of supersonic commercial aviation (Concorde, Boeing Sonic Cruiser) and frames the current regulatory shift toward allowing supersonic flight over land as the beginning of a 'Golden Age of Travel' driven by American innovation. The email promotes an upcoming replay of a Biotech Moment event while positioning supersonic travel infrastructure as an emerging investment theme.
• 2026-07-01PROMOThe Biotech Moment
  Here is Your Access Link
  Brownstone Research's The Biotech Moment is promoting a live event hosted by Jeff and Chris Hurt, claiming a biotech sector convergence begins July 23. The email provides an access link and urges subscribers to log in early to test audio/video, with scarcity messaging around the event timing and claimed returns.
• 2026-07-01EDITORIALThe Bleeding Edge
  The Next Generation of Medical Imaging
  Jeff Brown analyzes Midjourney Medical's new full-body ultrasound scanner as a potential 50-year breakthrough in medical imaging, powered by AI and semiconductor transducer technology. The email promotes Brown's live 'Biotech Moment' event covering biotech sector recovery driven by AI innovation and investment strategy.
• 2026-07-01EDITORIALChain of Thought
  Like Buying Bitcoin When It Was Still “Dangerous”
  Ben Lilly draws parallels between current regulatory hostility toward open-source AI models and historical opposition to Bitcoin, arguing that Anthropic's push to ban 'dangerous' open-source AI mirrors failed attempts to regulate decentralized finance. The email positions decentralized AI (DeAI) as facing the same prohibitionist policy pressures that crypto eventually overcame, with implications for innovation and competition.
• 2026-06-30EDITORIALThe Bleeding Edge
  Are We in a Simulation?
  Jeff Brown explores simulation theory and whether our reality is a computational simulation hosted by an advanced civilization, contextualizing the theory through science fiction and philosopher Nick Bostrom's 2003 paper. The email promotes an upcoming 8 p.m. ET presentation on biotech industry convergence and a strategy to capitalize on a coming 'golden age of biotech.'
• 2026-06-30PROMOThe Biotech Moment
  Your VIP Link Is About to Expire [Biotech Moment]
  Jeff Brown urgently promotes a live event (July 1, 8 p.m. ET) on a historic biotech convergence opportunity, claiming subscribers could average $4,000/month over four years. The email uses artificial scarcity (VIP link expiring, bonus report unavailable after event) to drive registration for exclusive access to his AI trading system and stock picks.
• 2026-06-29EDITORIALThe Bleeding Edge
  The Remarkable Success of the Reactor Pilot Program
  Jeff Brown analyzes the DOE's Reactor Pilot Program success in advancing fourth-generation nuclear fission technology, highlighting the ambitious July 4 deadline (250th Declaration of Independence anniversary) for three advanced reactors to achieve criticality under Executive Order 14301. The email covers the 10 companies and 11 projects selected for the program, positioning nuclear power as a critical infrastructure play amid a broader 'golden age of biotech' narrative promoted in an upcoming live event.
• 2026-06-29EDITORIALChain of Thought
  These Banks Know What’s Coming…
  Ben Lilly analyzes Standard Chartered's recent research predicting massive price appreciation for DeFi protocols Aave (42x to $3,500) and Uniswap (36x to $100) within 3.5 years, highlighting how a 172-year-old bank is embracing decentralized finance as an emerging asset class. The email positions Standard Chartered's willingness to recognize DeFi utility as contrasting with traditional financial institutions that lobby against innovation to protect market moats.